Taysha Gene Therapies had a revenue of 2.02M in the quarter ending Dec 31, 2024, with 13.09%. This bring the company's revenue in the last twelve months to 8.33M, Increased -15.96%. In the fiscal year ending Dec 31, 2024, Taysha Gene Therapies had annual revenue of 8.33M with -46.07% growth.